Dataset Open Access
Gündel, Daniel; Teodoro, Rodrigo; c, Friedrich-Alexander Ludwig a.; Heerklotz a., Anne; Toussaint, Magali; Deuther-Conrad, Winnie; Bormans d., Guy; Brust a., Peter; Kopka, Klaus; Moldovan, Rares-Petru; f, Rareş-Petru Moldovan
What is already known • Increased expression of the CB2R in the brain is linked to certain neuropathological diseases. • First clinical trials for CB2R-directed therapies are conducted. What this study adds • [18F]JHU94620-d8 provides the potential to quantify the CB2R receptor density in the brain by positron-emission-tomography. Clinical significance • Stratification of patients for CB2R-directed therapies and follow up of the treatment response is needed.
Name | Size | |
---|---|---|
18FJHU94620_gammacounter_results15Jan2020.xlsx
md5:55b39f77b300f1f1cbfdace12f5ea7cf |
15.4 kB | Download |
All versions | This version | |
---|---|---|
Views | 62 | 62 |
Downloads | 9 | 9 |
Data volume | 138.9 kB | 138.9 kB |
Unique views | 57 | 57 |
Unique downloads | 9 | 9 |